BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 20206335)

  • 1. DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.
    Flanagan JM; Cocciardi S; Waddell N; Johnstone CN; Marsh A; Henderson S; Simpson P; da Silva L; ; Khanna K; Lakhani S; Boshoff C; Chenevix-Trench G
    Am J Hum Genet; 2010 Mar; 86(3):420-33. PubMed ID: 20206335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.
    Holm K; Hegardt C; Staaf J; Vallon-Christersson J; Jönsson G; Olsson H; Borg A; Ringnér M
    Breast Cancer Res; 2010; 12(3):R36. PubMed ID: 20565864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
    Jönsson G; Naylor TL; Vallon-Christersson J; Staaf J; Huang J; Ward MR; Greshock JD; Luts L; Olsson H; Rahman N; Stratton M; Ringnér M; Borg A; Weber BL
    Cancer Res; 2005 Sep; 65(17):7612-21. PubMed ID: 16140926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
    Vos S; Moelans CB; van Diest PJ
    Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation epigenotypes in breast cancer molecular subtypes.
    Bediaga NG; Acha-Sagredo A; Guerra I; Viguri A; Albaina C; Ruiz Diaz I; Rezola R; Alberdi MJ; Dopazo J; Montaner D; Renobales M; Fernández AF; Field JK; Fraga MF; Liloglou T; de Pancorbo MM
    Breast Cancer Res; 2010; 12(5):R77. PubMed ID: 20920229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of CHEK2*1100delC-mutated breast carcinomas.
    Massink MP; Kooi IE; Martens JW; Waisfisz Q; Meijers-Heijboer H
    BMC Cancer; 2015 Nov; 15():877. PubMed ID: 26553136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
    Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
    Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
    Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations.
    Sensi E; Tancredi M; Aretini P; Cipollini G; Naccarato AG; Viacava P; Bevilacqua G; Caligo MA
    Breast Cancer Res Treat; 2003 Nov; 82(1):1-9. PubMed ID: 14672397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
    Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
    Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtypes of familial breast tumours revealed by expression and copy number profiling.
    Waddell N; Arnold J; Cocciardi S; da Silva L; Marsh A; Riley J; Johnstone CN; Orloff M; Assie G; Eng C; Reid L; Keith P; Yan M; Fox S; Devilee P; Godwin AK; Hogervorst FB; Couch F; ; Grimmond S; Flanagan JM; Khanna K; Simpson PT; Lakhani SR; Chenevix-Trench G
    Breast Cancer Res Treat; 2010 Oct; 123(3):661-77. PubMed ID: 19960244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families.
    Honrado E; Osorio A; Milne RL; Paz MF; Melchor L; Cascón A; Urioste M; Cazorla A; Díez O; Lerma E; Esteller M; Palacios J; Benítez J
    Mod Pathol; 2007 Dec; 20(12):1298-306. PubMed ID: 17885670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
    Chen Y; Wang Y; Salas LA; Miller TW; Mark K; Marotti JD; Kettenbach AN; Cheng C; Christensen BC
    Breast Cancer Res; 2019 Jan; 21(1):14. PubMed ID: 30683142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation variations in familial female and male breast cancer.
    Abeni E; Grossi I; Marchina E; Coniglio A; Incardona P; Cavalli P; Zorzi F; Chiodera PL; Paties CT; Crosatti M; De Petro G; Salvi A
    Oncol Lett; 2021 Jun; 21(6):468. PubMed ID: 33907578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.
    Park SY; Kwon HJ; Choi Y; Lee HE; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Mod Pathol; 2012 Feb; 25(2):185-96. PubMed ID: 22037257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular classification of familial non-BRCA1/BRCA2 breast cancer.
    Hedenfalk I; Ringner M; Ben-Dor A; Yakhini Z; Chen Y; Chebil G; Ach R; Loman N; Olsson H; Meltzer P; Borg A; Trent J
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2532-7. PubMed ID: 12610208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens.
    Rice JC; Ozcelik H; Maxeiner P; Andrulis I; Futscher BW
    Carcinogenesis; 2000 Sep; 21(9):1761-5. PubMed ID: 10964110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal-like breast cancer displays distinct patterns of promoter methylation.
    Lee JS; Fackler MJ; Lee JH; Choi C; Park MH; Yoon JH; Zhang Z; Sukumar S
    Cancer Biol Ther; 2010 Jun; 9(12):1017-24. PubMed ID: 20505321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients.
    Didraga MA; van Beers EH; Joosse SA; Brandwijk KI; Oldenburg RA; Wessels LF; Hogervorst FB; Ligtenberg MJ; Hoogerbrugge N; Verhoef S; Devilee P; Nederlof PM
    Breast Cancer Res Treat; 2011 Nov; 130(2):425-36. PubMed ID: 21286804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.